-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Acuitas Investments LLC Makes New $287,000 Investment in Semler Scientific, Inc. (OTCMKTS:SMLR)
Acuitas Investments LLC Makes New $287,000 Investment in Semler Scientific, Inc. (OTCMKTS:SMLR)
Acuitas Investments LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,800 shares of the medical equipment provider's stock, valued at approximately $287,000. Acuitas Investments LLC owned about 0.09% of Semler Scientific at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Legal Advantage Investments Inc. increased its position in shares of Semler Scientific by 15.0% during the first quarter. Legal Advantage Investments Inc. now owns 19,119 shares of the medical equipment provider's stock worth $948,000 after acquiring an additional 2,500 shares during the period. Anchor Capital Advisors LLC acquired a new position in Semler Scientific in the first quarter valued at $1,573,000. Cannon Global Investment Management LLC acquired a new position in Semler Scientific in the first quarter valued at $362,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Semler Scientific during the first quarter worth about $275,000. Finally, Financial Management Professionals Inc. boosted its stake in shares of Semler Scientific by 197.1% during the first quarter. Financial Management Professionals Inc. now owns 3,013 shares of the medical equipment provider's stock worth $149,000 after buying an additional 1,999 shares during the period. 44.69% of the stock is currently owned by institutional investors and hedge funds.
Get Semler Scientific alerts:Semler Scientific Trading Up 18.8 %
Shares of OTCMKTS SMLR opened at $39.50 on Thursday. The firm's 50-day moving average is $29.71 and its 200-day moving average is $45.49. Semler Scientific, Inc. has a 1 year low of $27.02 and a 1 year high of $153.21. The firm has a market capitalization of $268.21 million, a PE ratio of 24.53 and a beta of 0.89.
Semler Scientific (OTCMKTS:SMLR – Get Rating) last issued its earnings results on Monday, May 2nd. The medical equipment provider reported $0.41 EPS for the quarter, missing the consensus estimate of $0.51 by ($0.10). Semler Scientific had a return on equity of 30.85% and a net margin of 24.08%. The business had revenue of $14.02 million for the quarter, compared to analyst estimates of $14.82 million. As a group, equities research analysts anticipate that Semler Scientific, Inc. will post 1.37 earnings per share for the current fiscal year.Analyst Upgrades and Downgrades
Separately, B. Riley dropped their target price on shares of Semler Scientific from $70.00 to $60.00 in a report on Tuesday, May 3rd.
About Semler Scientific
(Get Rating)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Energy Transfer Is A Value Among High-Yield Energy Infrastructure
- Devon Energy Looks Attractive if You Look Past the Headlines
- 3 Low Priced Stocks With Good Growth Prospects
- Warner Brothers Discovery is a Powerhouse Entertainment Play
- The Institutions Are Buying Under Armor Again
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
Acuitas Investments LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,800 shares of the medical equipment provider's stock, valued at approximately $287,000. Acuitas Investments LLC owned about 0.09% of Semler Scientific at the end of the most recent reporting period.
根据Acuitas Investments LLC最近提交给美国证券交易委员会(Securities And Exchange Commission)的13F文件，Acuitas Investments LLC在第一季度购买了Semler Science，Inc.(OTCMKTS：SMLR-GET Rating)的新股票头寸。该基金购买了这家医疗设备供应商的5,800股股票，价值约28.7万美元。在最近的报告期结束时，Acuitas Investments LLC拥有Semler Science约0.09%的股份。
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Legal Advantage Investments Inc. increased its position in shares of Semler Scientific by 15.0% during the first quarter. Legal Advantage Investments Inc. now owns 19,119 shares of the medical equipment provider's stock worth $948,000 after acquiring an additional 2,500 shares during the period. Anchor Capital Advisors LLC acquired a new position in Semler Scientific in the first quarter valued at $1,573,000. Cannon Global Investment Management LLC acquired a new position in Semler Scientific in the first quarter valued at $362,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Semler Scientific during the first quarter worth about $275,000. Finally, Financial Management Professionals Inc. boosted its stake in shares of Semler Scientific by 197.1% during the first quarter. Financial Management Professionals Inc. now owns 3,013 shares of the medical equipment provider's stock worth $149,000 after buying an additional 1,999 shares during the period. 44.69% of the stock is currently owned by institutional investors and hedge funds.
其他几家机构投资者和对冲基金也改变了他们在该股的头寸。Legal Advantage Investments Inc.在第一季度将其在Semler Science的股票头寸增加了15.0%。在此期间，Legal Advantage Investments Inc.增持了2,500股股票，目前持有19,119股这家医疗设备供应商的股票，价值948,000美元。Anch Capital Advisors LLC在第一季度收购了Semler Science的一个新头寸，价值1,573,000美元。Canon Global Investment Management LLC在第一季度收购了Semler Science的一个新头寸，价值36.2万美元。Mesirow Financial Investment Management Inc.在第一季度收购了Semler Science价值约275,000美元的新股。最后，金融管理专业公司在第一季度增持了赛姆勒科学公司197.1%的股份。金融管理专业人士公司在此期间又购买了1,999股，现在拥有这家医疗设备提供商的3,013股股票，价值149,000美元。44.69%的股票目前由机构投资者和对冲基金持有。
Semler Scientific Trading Up 18.8 %
塞姆勒科学公司股价上涨18.8%
Shares of OTCMKTS SMLR opened at $39.50 on Thursday. The firm's 50-day moving average is $29.71 and its 200-day moving average is $45.49. Semler Scientific, Inc. has a 1 year low of $27.02 and a 1 year high of $153.21. The firm has a market capitalization of $268.21 million, a PE ratio of 24.53 and a beta of 0.89.
周四，OTCMKTS SMLR的股价开盘报39.50美元。该公司的50日移动均线切入位为29.71美元，200日移动均线切入位为45.49美元。塞姆勒科学公司的一年低点为27.02美元，一年高位为153.21美元。该公司市值为2.6821亿美元，市盈率为24.53倍，贝塔系数为0.89。
Analyst Upgrades and Downgrades
分析师升级和下调评级
Separately, B. Riley dropped their target price on shares of Semler Scientific from $70.00 to $60.00 in a report on Tuesday, May 3rd.
另外，B.莱利在5月3日星期二的一份报告中将Semler Science的目标价从70.00美元下调至60.00美元。
About Semler Scientific
关于塞姆勒科学公司
(Get Rating)
(获取评级)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Semler Science，Inc.提供技术解决方案，以提高美国医疗保健提供者的临床效果和效率。该公司的产品包括QuantaFlo，这是一种四分钟的办公室内血液流动测试，使医疗保健提供者能够使用血流测量作为患者血管状况检查的一部分。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Energy Transfer Is A Value Among High-Yield Energy Infrastructure
- Devon Energy Looks Attractive if You Look Past the Headlines
- 3 Low Priced Stocks With Good Growth Prospects
- Warner Brothers Discovery is a Powerhouse Entertainment Play
- The Institutions Are Buying Under Armor Again
- 免费获取StockNews.com关于Semler Science(SMLR)的研究报告
- 能源转移是高产出能源基础设施的价值所在
- 如果你不去看头条新闻，德文能源看起来很有吸引力
- 3只具有良好增长前景的低价股票
- 华纳兄弟探索是Powerhouse娱乐公司的一部戏剧
- 这些机构再次在Armor下买入
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).
想看看其他对冲基金持有SMLR的情况吗？访问HoldingsChannel.com获取Semler Science，Inc.(OTCMKTS：SMLR-GET Rating)的最新13F文件和内幕交易。
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
接受《塞姆勒科技日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Semler Science及相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧